Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.

Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RT.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1615-1623. doi: 10.2215/CJN.02510317. Epub 2017 Sep 7.

2.

The rising incidence of nonalcoholic fatty liver disease.

Wisocky J, Paul S.

Nurse Pract. 2017 Jul 15;42(7):14-20. doi: 10.1097/01.NPR.0000520420.17084.bb.

PMID:
28562448
3.

Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis.

Shah RV, Anderson A, Ding J, Budoff M, Rider O, Petersen SE, Jensen MK, Koch M, Allison M, Kawel-Boehm N, Wisocky J, Jerosch-Herold M, Mukamal K, Lima JAC, Murthy VL.

JACC Cardiovasc Imaging. 2017 Sep;10(9):1016-1027. doi: 10.1016/j.jcmg.2016.10.024. Epub 2017 Mar 15.

4.

Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy.

Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, Babitt JL, Tangren JS, Hashemi N, Lundquist AL, Williams WW, Mount DB, Andersson KL, Rennke HG, Smith RN, Colvin R, Thadhani RI, Chung RT.

Kidney Int Rep. 2016 Sep;1(3):135-143.

5.

Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.

Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT.

Hepatology. 2016 Feb;63(2):408-17. doi: 10.1002/hep.28297. Epub 2015 Dec 11.

6.

Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.

Hundemer GL, Sise ME, Wisocky J, Ufere N, Friedman LS, Corey KE, Chung RT.

Infect Dis (Lond). 2015;47(12):924-9. doi: 10.3109/23744235.2015.1078908. Epub 2015 Aug 18.

7.

Enhancing our understanding of current therapies for hepatitis C virus (HCV).

Gogela NA, Lin MV, Wisocky JL, Chung RT.

Curr HIV/AIDS Rep. 2015 Mar;12(1):68-78. doi: 10.1007/s11904-014-0243-7. Review.

Supplemental Content

Loading ...
Support Center